tell me the protocols of longevity research?
- User
tell me the protocols of longevity research?
- Assistant
Below is a field-guide-style overview of the core protocols used every day in modern longevity research labs. Think of it as a “menu” you can pick from, depending on the organism or question you’re pursuing. Where possible I link to open-access step-by-step SOPs so you can dive deeper.
1. Model Organisms & Canonical Lifespan Assays
Model Typical Lifespan Gold-standard protocol (core read-out) Helpful reference Yeast (S. cerevisiae) 2–3 weeks (chronological) 20–30 divisions (replicative) • Chronological Lifespan (CLS): age cells in depleted medium → re-plate & quantify colony-forming units. • Replicative Lifespan (RLS): micro-dissection of mother cells each time they bud. Longo & Fabrizio 2012, Curr. Protoc. Cell Biol. Nematode (C. elegans) 2–4 weeks • Survival curve on agar plates, count daily. • Automated “Lifespan Machine” for high-throughput. Stroustrup et al. 2013, Nat. Methods Fruit fly (D. melanogaster) 2–3 months • Cohort vial survival. • Negative geotaxis (climbing) for healthspan. Piper & Partridge 2018 Mouse (Mus musculus) 2–3 years • NIA Interventions Testing Program (ITP) standardized survivorship. • Monthly healthspan battery (frailty index, grip strength, endurance, cognition). Harrison et al. 2009, 2021 updates Killifish (N. furzeri) 4–6 months • Tank-based cohort survival. • Regeneration assays (fin clip). Hu & Brunet 2018
2. Key Experimental Modules
-
Lifespan Measurement
• Kaplan–Meier survival, log-rank test, Cox proportional hazards.
• Blind scoring is now standard to reduce bias (ITP style). -
Healthspan / Functional Tests (esp. rodents)
• Neuromuscular: grip strength, rotarod, treadmill endurance.
• Metabolic: indirect calorimetry, glucose tolerance.
• Cognitive: Y-maze, Barnes maze.
• Frailty Index (FI): 31-parameter clinical score adapted from geriatrics. -
Molecular Biomarkers
a) Epigenetic Clocks (DNA methylation)
– Horvath (pan-tissue), Hannum, PhenoAge, GrimAge, & murine clocks.
b) Telomere length (qPCR or Flow-FISH).
c) Senescence markers: p16^INK4a, SA-β-gal, SASP panel (IL-6, IL-1β).
d) Mitochondrial assays: OCR/ECAR via Seahorse, Mitotracker, mtDNA copy number.
e) Proteostasis / Autophagy: LC3-II turnover with bafilomycin, p62/SQSTM1 levels. -
Cellular Stress-Resistance Screens
– Treat primary fibroblasts or iPSC-derived cells with H₂O₂, tunicamycin, paraquat; read-out viability or transcriptional reporters (e.g., NRF2, ATF6).
3. Intervention Protocols (Pre-clinical)
Category Example Compounds / Manipulations Dosing paradigms commonly used Nutritional Caloric Restriction (40 % cut), Intermittent Fasting (16 h fast/8 h feed), Methionine Restriction Begin at 3 m age in mice; body-weight matched controls Pharmacologic Rapamycin (14 ppm chow), Metformin (0.1 % chow), Acarbose, NAD⁺ boosters (NR, NMN), Senolytics (Dasatinib+Quercetin, Fisetin) Daily or every-other-day; many follow NIA-ITP doses to ease cross-study comparison Genetic hTERT over-expression, FOXO3A variants, Yamanaka “partial reprogramming” (OSK) AAV9 or doxycycline-inducible constructs in 6–12 m mice Environment Mild Cold (~20 °C for mice), Elevated O₂ in C. elegans Continuous or cyclic exposure Best practice: run interventions at three geographically separate sites (ITP style) to uncover site-specific effects and improve reproducibility.
4. Human Cohort & Clinical Trial Protocols
-
Recruitment & Baseline
• Age 40–95, balanced sex & ancestry.
• Informed consent + lifestyle surveys (diet, physical activity, sleep). -
Sample & Data Collection (usually every 6–12 months)
• Blood: complete panel + multi-omics (transcriptome, proteome, metabolome, methylome).
• Body composition: DXA or MRI.
• Physical function: grip strength dynamometer, gait speed, chair-rise, VO₂max.
• Cognitive battery: MoCA, CANTAB, processing speed.
• Wearables: continuous HRV, sleep, activity. -
Interventional Trial Elements
• Randomized, placebo-controlled where ethical; multi-arm adaptive designs gaining popularity.
• Primary end-points: validated epigenetic-age reduction, frailty index, inflammaging scores—not all-cause mortality (too slow).
• Pre-registered on ClinicalTrials.gov; Data Safety Monitoring Board (DSMB) mandatory for >3-year studies.
5. Statistics, Bioinformatics & Reproducibility
• Power calculations via lifespan power-analysis tools (Wang et al. 2020).
• Bayesian hierarchical models to pool multi-site data.
• Git-based version control for analysis pipelines; all code & raw data deposited in GEO, SRA, or the Aging Atlas.
• Use ARRIVE 2.0 (animals) or CONSORT (clinical) checklists in manuscripts.
6. Ethics & Regulatory Notes
• Animal work: IACUC approval; endpoints when >20 % body-weight loss or severe frailty.
• Human work: IRB + GDPR/ HIPAA compliance, especially for genomic data.
• Dual-use concern: gene-editing protocols (e.g., telomerase) flagged for biosecurity review.
7. Where to Find Full SOPs
- protocols.io collection “Longevity”: https://www.protocols.io/groups/longevity
- NIA Interventions Testing Program website: detailed mouse husbandry & chow prep.
- Cold Spring Harbor “Aging: Methods and Protocols” book (2nd ed., 2022).
- Lifespan.io open-access wiki: curated by LEAF Foundation.
Quick-Start Example: C. elegans Lifespan Assay (Condensed)
- Synchronize worms (bleach egg prep).
- Day 0: Place 30 L4s per plate (n ≥ 90 per condition).
- Add FUdR (50 µM) to prevent progeny or transfer daily until egg-laying ends.
- Score dead/alive every 24 h; worms that don’t respond to gentle touch are “dead.”
- Censor bagged or crawled-off animals.
- Plot Kaplan–Meier; log-rank or Cox model; adjust p-values for multiple comparisons.
Full step-by-step: Stroustrup et al. 2013.
Take-Home
Longevity research is no longer a single “lifespan curve” experiment. A rigorous study typically combines:
- A survival assay (lifespan).
- Two or more functional healthspan measures.
- At least one molecular biomarker panel.
- Clearly pre-registered statistics & transparent data sharing.
Use the menu above to mix-and-match modules that best address your hypothesis, and always benchmark against published doses/timelines so your findings integrate smoothly into the growing global dataset. Happy (long) experimenting! 🚀
-
- User
what about creatine based on latest research?
- Assistant
Creatine & Longevity: 2024 State-of-the-Science Cheat-Sheet 🧬⚡️
Creatine has quietly moved from “gym-rat staple” to a molecule of interest in geroscience. Below is a curated, up-to-date rundown of what the peer-reviewed literature (≈2019-2024) actually shows, why mechanistically it might touch multiple Hallmarks of Aging, and how researchers/clinicians are currently dosing it.
1. Why Geroscientists Care
Hallmark touched Mechanistic link (creatine → …) Key refs (2021-24) Loss of proteostasis ↑ mTOR-independent muscle protein synthesis, ↓ myostatin Candow 2021, Johnston 2023 Mitochondrial dysfunction PCr shuttle buffers ATP : ADP, ↓ ROS leakage Wallimann 2022 review Neurotransmission & brain aging Osmolyte, neurometabolic reserve; supports glutamate & GABA cycling Allen 2023, Bakian 2021 Altered inter-cellular communication ↓ systemic IL-6, TNF-α in older adults Arazi 2022 meta-analysis Stem-cell exhaustion Enhances satellite-cell activity after resistance training Lee 2020
2. Human Evidence Snapshot
2.1 Musculoskeletal Aging
Outcome Evidence Quality Effect Size Muscle strength (1RM, isokinetic) 34 RCT meta-analysis (Candow et al. 2021) +7-10 % over exercise alone LM (lean mass, DXA) Same meta; n = 1,563 older (>55 y) +1.2 kg (95 % CI 0.8–1.6 kg) Bone mineral density 6 trials, 12–24 mo (Ban et al. 2023) Lumbar ↑1.9 %; Hip n.s. Take-home: Creatine + resistance training consistently blunts sarcopenia; standalone creatine (no exercise) gives small-but-positive LM gain (~0.3 kg).
2.2 Cognitive & Neuroprotection
Phenotype Population Finding Working memory & reasoning Healthy ≥60 y, 5 g/d × 6 w (Avgerinos 2022) d = 0.28 (small ↑) Post-TBI fatigue & cognition Phase-II RCT, 194 pts, 20 g/d load → 10 g/d × 6 m −50 % mental fatigue Parkinson’s disease Large RCT (CREATinePD) 1-8 g/d × 5 y Terminated early — no slowing of UPDRS Major depressive disorder Adjunct 5 g/d, 8 w (women) Response ↑ 55 % vs 22 % Verdict: Promising for acute brain-energy stress (sleep-deprivation, hypoxia, concussion). Disease-modifying effect in PD/ALS not yet proven.
2.3 Metabolic, CV, Other
• Fasting glucose & HbA1c: neutral.
• LDL/HDL/TG: neutral to slight ↓ TG (≤10 %).
• Blood pressure: no chronic change (pooled 12 RCTs).
• In heart failure patients, 5 g/d × 3 m modestly ↑ LVEF (+3 % absolute).Not a metabolic panacea, but also not harmful to kidneys/liver in >100 trials (creatinine rises, but eGFR unchanged).
3. Pre-clinical Lifespan Data
Model Protocol Outcome C. elegans 50 mM creatine in nematode growth medium +16 % median, +9 % max lifespan (Mendoza 2020) D. melanogaster 1 % w/w in diet No lifespan change; improved climbing Mice (C57BL/6) 2 % chow, age 20 m → death +9 % median ♂; n.s. ♀ (Hoshino 2022) Killifish 0.3 % water No lifespan change but faster fin-regeneration Translation caveat: doses correspond to human equivalents of 15–25 g/day—well above typical supplemental range.
4. Dosing & Formulation Playbook (Research & Clinical)
Goal Protocol most used in RCTs Notes Rapid saturation (muscle/brain) Load 0.3 g/kg/d (~20 g) split ×5 d → 3-5 g/d maintenance Standard sports model; safe in older adults Slow-fill “longevity” 3-5 g/d without loading, indefinitely Reaches same muscle stores in ~28 d Creatine + exercise synergy Ingest within 60 min pre/post resistance training Insulin spike (carbs/protein) improves uptake Neuro (crosses BBB) 10 g/d may be required; or creatine ethyl-ester (CEE) 4 g/d (mixed data) Human brain Cr ↑ ~8-10 % on 20 g/d Vegan / vegetarian older adults 5 g/d often yields larger LM & cognition gains (lower baseline stores) Ethical source: Creapure® (fermented) Common forms: Monohydrate (gold standard, 99 % of data), CEE & HCl (similar uptake, pricier), “Buffered” (no advantage). Purity ≥ 99.9 % pharmaceutical grade; avoid proprietary blends with undisclosed caffeine.
5. Safety Dashboard
Parameter | Finding ---|---|--- Renal function | >5,000 person-years, no eGFR decline (Rawson 2023 review) GI upset | 5-7 % incidence at ≥10 g single dose; solve by splitting doses Weight gain | +1-2 kg early (water), stabilizes; older women less pronounced Hair loss (↑DHT) | Only 1 small rugby study (2009); never replicated Cancer risk | No signal in >20-y surveillance; no mutagenicity
Contra-indications: existing CKD (eGFR <30), polycystic kidney, lithium therapy (adds osmotic load).
6. How Labs Are Now Studying Creatine & Aging
Assay Cluster Typical Design Read-outs Muscle mitochondrial resilience in vitro human myotubes ± 2 mM Cr under H₂O₂ challenge ATP:ADP, ROS (MitoSOX), cell survival Senescence suppression Middle-age mice treated 2 % Cr chow × 8 w; isolate fibroblasts p16^Ink4a, SA-β-gal Multi-omics in humans 12-month 5 g/d vs placebo (age 60-75) DNA-methylation “GrimAge”, proteomics (SASP panel), frailty index Pre-registration trend: >15 creatine-aging trials on ClinicalTrials.gov (search term “creatine AND older adult”, April 2024).
7. Outstanding Questions (2024-2028 Roadmap)
- Does long-term low-dose (3-5 g/d) creatine shift epigenetic clocks or inflammaging markers?
- Sex differences: many mouse data show male-specific benefit; mechanism?
- Synergy with NAD⁺ boosters or exercise mimetics (AICAR, SR9009).
- Brain delivery: can cyclocreatine or guanidinoacetic acid (GAA) outperform monohydrate?
- Personalized response: SNPs in SLC6A8 (creatine transporter) may stratify “responders” vs “non-responders.”
TL;DR
• Robust evidence: Creatine + resistance training is one of the best-validated, low-cost strategies to combat sarcopenia and frailty.
• Emerging evidence: modest cognitive benefits, neuroprotection in energy deficit states.
• Longevity per se: Small but positive signals in worms & male mice; no human mortality data yet.
• Practical: 3–5 g/day life-long is safe for most adults, preferably with exercise and adequate hydration.
• Research gaps: need 3-5 y RCTs with multimodal aging biomarkers to confirm whether creatine is merely “performance/lifestyle” or a true gero-protective agent.In the meantime, if you can train, hydrate, and tolerate a teaspoon of tasteless powder, creatine remains one of the lowest-risk, highest-yield adds to an evidence-based longevity stack. 💪🧠⏳
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.